mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
2e-05 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0004 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |